- Home
- GDTC vs SWIN Comparison
GDTC vs SWIN Comparison
Compare GDTC & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- SWIN
- Stock Information
- Founded
- GDTC 2018
- SWIN 2017
- Country
- GDTC Singapore
- SWIN Hong Kong
- Employees
- GDTC N/A
- SWIN N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- SWIN
- Sector
- GDTC Health Care
- SWIN
- Exchange
- GDTC Nasdaq
- SWIN Nasdaq
- Market Cap
- GDTC 21.5M
- SWIN 214.1M
- IPO Year
- GDTC 2023
- SWIN 2023
- Fundamental
- Price
- GDTC $1.89
- SWIN $3.93
- Analyst Decision
- GDTC Buy
- SWIN
- Analyst Count
- GDTC 1
- SWIN 0
- Target Price
- GDTC $5.00
- SWIN N/A
- AVG Volume (30 Days)
- GDTC 18.1K
- SWIN 208.1K
- Earning Date
- GDTC 01-01-0001
- SWIN 08-21-2025
- Dividend Yield
- GDTC N/A
- SWIN N/A
- EPS Growth
- GDTC N/A
- SWIN N/A
- EPS
- GDTC N/A
- SWIN N/A
- Revenue
- GDTC $368,838.00
- SWIN $3,316,000.00
- Revenue This Year
- GDTC $5.37
- SWIN $29.79
- Revenue Next Year
- GDTC N/A
- SWIN $54.60
- P/E Ratio
- GDTC N/A
- SWIN N/A
- Revenue Growth
- GDTC N/A
- SWIN N/A
- 52 Week Low
- GDTC $1.20
- SWIN $1.16
- 52 Week High
- GDTC $4.05
- SWIN $4.40
- Technical
- Relative Strength Index (RSI)
- GDTC 37.08
- SWIN 62.05
- Support Level
- GDTC $1.85
- SWIN $3.70
- Resistance Level
- GDTC $1.95
- SWIN $3.99
- Average True Range (ATR)
- GDTC 0.10
- SWIN 0.35
- MACD
- GDTC -0.02
- SWIN -0.03
- Stochastic Oscillator
- GDTC 28.00
- SWIN 93.02
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About SWIN Solowin Holdings
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.